13G FILING

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 9, 1999

Accession Number

0000902219-99-000095

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →